As better understanding of health and sickness has led to superior ways of preventing, diagnosing, and treating diseases, the health of most Americans has improved dramatically. However, ample evidence indicates that some Americans do not receive the full benefits of high quality care. Specifically, extensive disparities in health care related to race, ethnicity, and socioeconomic status have been demonstrated by a substantial body of public health, social science, and health services research and confirmed by previous releases of the National Healthcare Disparities Report.
Quality health care means doing the right thing, at the right time, in the right way, for the right people—and having the best possible results.1 Quality health care is care that is: 2
Health care quality is measured in several ways including:
This chapter presents new information about disparities in the quality of health care in America. The measures used here are the same as those used in the National Healthcare Quality Report (NHQR), and this chapter is constructed to mirror sections in the NHQR—effectiveness, patient safety, timeliness, and patient centeredness. Due to constraints on the length of this report, only a subset of the core measures is presented. Effectiveness of care is presented in Chapter 2 under eight clinical condition or care setting areas: cancer; diabetes; end stage renal disease (ESRD); heart disease; HIV and AIDS; mental health and substance abuse; respiratory diseases; and nursing home, home health, and hospice care. Maternal and child health is discussed in Chapter 4, Priority Populations.
As in previous NHDRs, this chapter's discussion on quality of care focuses on disparities in quality related to race, ethnicity, and socioeconomic status in the general U.S. population. Disparities in quality of care within specific priority populations are presented in Chapter 4. This chapter also presents analyses of changes over time by race, ethnicity, and socioeconomic status, as well as some stratified analyses.
Finally, new composite measures are introduced in this year's NHDR, including timing of antibiotics to prevent postoperative wound infection, communication with doctors in the hospital, communication with nurses in the hospital, communication about medications in the hospital, discharge information from the hospital, postoperative complications, and complications of central venous catheters. For composite details, go to Chapter 1, Introduction and Methods.
In the effectiveness section of this chapter, measures are organized into several categories as related to the patient's need for preventive care, treatment of acute illness, and chronic disease management. There is sizable overlap among these categories, and some measures may be considered to belong in more than one category. Outcome measures are particularly difficult to categorize when prevention, treatment, and management all play important roles. Nevertheless, for the purposes of this report, measures are placed into categories that best fit the general descriptions below:
Note that findings for women and children, which parallel those presented in the NHQR for maternal and child health, are presented in the sections on women and children in Chapter 4. Measures presented in effectiveness fall within the three components of health care need as listed below. (For findings related to all core measures of effectiveness, go to Tables 2.1a and 2.1b.)
| Section | Measure |
|---|---|
| Prevention: | |
| Cancer (colorectal) | Screening for colorectal cancer |
| Heart disease | Counseling about overweight* |
| Heart disease | Counseling about exercise |
| Respiratory diseases | Pneumococcal vaccination |
| Maternal and child health (women) | Screening for colorectal cancer |
| Maternal and child health (women) | Prenatal care/maternal care |
| Maternal and child health (children) | Vaccinations |
| Maternal and child health (children) | Vision care |
| Maternal and child health (children) | Counseling about overweight*/healthy eating |
| Treatment: | |
| Heart disease | Recommended hospital care for heart failure |
| Mental health and substance abuse | Receipt of treatment for depression |
| Mental health and substance abuse | Treatment for illicit drug use |
| Respiratory diseases | Recommended hospital care for pneumonia |
| Nursing home, home health, and hospice care | Improved walking or moving |
| Nursing home, home health, and hospice care | Hospitalization of home care patients |
| Maternal and child health (women) | Recommended hospital care for heart attack |
| Maternal and child health (children) | Hospital admissions for gastroenteritis |
| Management: | |
| Diabetes | Receipt of recommended services for diabetes |
| Diabetes | Hemoglobin, cholesterol, blood pressure control* |
| End stage renal disease (ESRD) | Adequacy of hemodialysis |
| End stage renal disease (ESRD) | Registration for transplantation |
| HIV and AIDS | New AIDS cases |
| HIV and AIDS | PCP and MAC prophylaxis* |
| Respiratory diseases | Management of asthma for long-term control* i |
| Nursing home, home health, and hospice care | Use of physical restraints |
| Nursing home, home health, and hospice care | Presence of pressure sores |
| Nursing home, home health, and hospice care | Hospice care* ii |
| Maternal and child health (women) | New AIDS cases |
| Maternal and child health (children) | Hospital admissions for asthma* |
* Supplemental measure
i This year's report includes four supplemental measures of asthma management from the National Asthma Survey as follows: counseling persons with asthma about recognizing an attack, counseling persons with asthma about changing their environment, use of a controller medication, and receipt of an asthma management plan.
ii This year's report includes two supplemental measures of hospice care from the National Hospice and Palliative Care Organization Family Evaluation of Hospice Care: hospice patients who did not receive the right amount of medicine for pain and hospice patients who did not receive end-of-life care consistent with their stated wishes.
| Type of statistic | Number |
|---|---|
| Number of deaths (2006 est.) | 564,8303 |
| Cause of death rank (2003) | 2nd4 |
| Number of Americans that have been diagnosed with cancer (2002 est.) | 10,100,0003 |
| New cases of cancer (2006 est.) | 1,399,7903 |
| New cases of colorectal cancer (2006 est.) | 148,6103 |
| Total costiii (2006) | $206.3 billion5 |
| Direct costsiv (2006) | $78.2 billion5 |
| Cost effectivenessv of colorectal cancer screening | $0-$14,000/QALY6 |
| Cost effectiveness of cervical cancer screening | $14,000-$35,000/QALY6 |
iiiTotal cost is composed of the cost of medical care itself (direct cost) and the economic costs of morbidity and mortality (indirect cost).
ivDirect costs are defined as "personal health care expenditures for hospital and nursing home care, drugs, home care, and physician and other professional services."5
vCost effectiveness is measured here by the average net cost of each quality adjusted life year (QALY) that is saved by the provision of a particular health intervention. QALYs are a measure of a year of life adjusted for its value: 1 year in perfect health is equal to 1.0 QALY, and a year in poor health would be something less than 1.0. A lower cost per QALY saved indicates a greater degree of cost effectiveness.
Ensuring that all populations have access to appropriate cancer screening services is a core element of reducing cancer health disparities.7 This year the NHDR focuses on colorectal cancer; findings for breast cancer are found in the 2005 NHDR. Screening for colorectal cancer—including fecal occult blood testing, sigmoidoscopy, colonoscopy, and proctoscopy—is an effective way of reducing new cases of late stage disease and mortality caused by this cancer.
Figure 2.1. Adults age 50 and over who report having ever received a sigmoidoscopy, colonoscopy, or proctoscopy or who report fecal occult blood test within the past 2 years by race, ethnicity, income, and education, 2000-2003

Key: AI/AN=American Indian/Alaska Native.
Source: National Health Interview Survey, 2000, 2003.
Reference population: Adults age 50 and over in the civilian noninstitutionalized population.
Note: Age adjusted to the 2000 U.S. standard population.
Racial and ethnic minorities are disproportionately of lower socioeconomic status.vi, 8 To distinguish the effects of race, ethnicity, income, and education on cancer screening, this measure is stratified by income and education level.
Figure 2.2. Adults age 50 and over who reported having ever received a sigmoidoscopy, colonoscopy, or proctoscopy, or a fecal occult blood test within the past 2 years by race and ethnicity, stratified by income, 2003
Source: National Health Interview Survey, 2003.
Reference population: Adults age 50 and over in the civilian noninstitutionalized population.
vi As described in Chapter 1, Introduction and Methods, income and educational attainment are used to measure socioeconomic status in the NHDR.
Figure 2.3. Adults age 50 and over who reported having ever received a sigmoidoscopy, colonoscopy, or proctoscopy, or a fecal occult blood test within the past 2 years by race and ethnicity, stratified by education, 2003
Source: National Health Interview Survey, 2003.
Reference population: Adults age 50 and over in the civilian noninstitutionalized population.
| Type of statistic | Number |
|---|---|
| Number of deaths (2003) | 73,9654 |
| Cause of death rank (2003) | 6th4 |
| Total number of Americans with diabetes (2005) | 20,800,0009 |
| New cases (age 20 and over, 2005) | 1,500,0009 |
| Total cost (2002) | $132 billion10 |
| Direct medical costs (2002) | $92 billion10 |
Effective management of diabetes includes HbA1cvii testing, eye examination, and foot examination in the past year, as well as appropriate influenza immunization and lipid management.11,12,13
Figure 2.4. Adults age 40 and over with diabetes who had three recommended services for diabetes in the past year, by race, ethnicity, family income, and education, 2000-2003
Source: Medical Expenditure Panel Survey, 2000-2003.
Reference population: Civilian, noninstitutionalized population of adults age 40 and older.
Note: Recommended services for diabetes are: (1) HBA1c testing, (2) retinal eye examination, and (3) foot examination in past year. Data include persons with both type 1 and type 2 diabetes. Rate is age adjusted to the 2000 standard population.
vii HbA1c is glycosylated hemoglobin and provides information about control of blood sugar levels.
viii For diabetes care findings for AI/ANs, see text on the focus on Indian Health Service facilities in Chapter 4, Priority Populations.
People with diagnosed diabetes often have other cardiovascular risk factors such as high blood pressure and high cholesterol. The combination of these conditions with diabetes increases the likelihood of complications from diabetes, such as heart disease and stroke. Therefore, in addition to controlling blood sugar levels, diabetes management often includes treating high blood pressure and high cholesterol. HbA1c testing determines the average blood sugar level over 2-3 months and provides information about control of blood sugar levels. Checking blood pressure and cholesterol levels is also needed to assess control of these risk factors.ix
Figure 2.5. Adults age 40 and over with diagnosed diabetes with HbA1c, total cholesterol, and blood pressure under control, by race/ethnicity and income, 1988-1994 and 1999-2002
Source: National Health and Nutrition Examination Survey, 1988-1994 and 1999-2002.
Reference population: Civilian noninstitutionalized population with diabetes age 40 and over.
Note: Whites and Blacks are non-Hispanic groups; "Mexican American" is used in place of "Hispanic" because the NHANES is designed to provide estimates for this group rather than all Hispanics. Age adjusted to the 2000 U.S. standard population
ix Blood pressure control guidelines were updated in 2005. Previously, having a blood pressure reading of <140/90 mm Hg was considered under control. For this measure, the new threshold of <140/80 mm Hg has been applied to historical data for the sake of consistency and comparability.
| Type of statistic | Number |
|---|---|
| Total ESRD deaths (2003) | 82,58814 |
| Total cases (2003) | 452,95714 |
| New cases (2003) | 102,56714 |
| Total ESRD program expenditures (2003) | $27.3 billion14 |
End stage renal disease is failure of the kidneys to filter waste products from the body, necessitating dialysis.15 Adequacy of dialysis is important to the 70% of ESRD patients on dialysis.
Figure 2.6. Hemodialysis patients age 18 and over with adequate dialysis (urea reduction ratio 65% or higher), by race and ethnicity, 2001-2004
Key: AI/AN=American Indian or Alaska Native.
Source: ESRD Clinical Performance Measures Project, 2001-2004.
Reference population: ESRD hemodialysis patients age 18 and over.
Kidney transplantation often allows persons with ESRD to continue a lifestyle most similar to that which they had before their kidney failure.16 It is important that persons with ESRD are registered on the waiting list for kidney transplantation to increase the likelihood of transplantation. However, there are many more people on the waiting list for transplantation than people who receive transplantation; thus, being on the waiting list does not ensure one will receive a transplant.17
Figure 2.7. Dialysis patients under age 70 registered on the waiting list for transplantation, by race and ethnicity, 1998-2003
Key: AI/AN=American Indian or Alaska Native.
Source: U.S. Renal Data System, 1998-2003.
Reference population: ESRD hemodialysis patients and peritoneal dialysis patients age 0-70.
| Type of statistic | Number |
|---|---|
| Number of deaths (2003) | 684,4624 |
| Cause of death rank (2003) | 1st4 |
| Number of cases of coronary heart disease each year | 13,200,00018 |
| Number of cases of heart failure each year | 5,000,00018 |
| Number of cases of high blood pressure each year | 65,000,00018 |
| Number of heart attacks each year | 7,200,00018 |
| Number of new cases of congestive heart failure each year | 550,00018 |
| Total cost of cardiovascular disease (2006 est.) | $403.0 billion5 |
| Total cost of congestive heart failure (2006 est.) | $29.6 billion18 |
| Direct medical costs of cardiovascular disease (2005 est.) | $257.6 billion5 |
| Cost effectiveness of hypertension screening | $14,000-$35,000/QALY6 |
| Cost effectiveness of aspirin chemoprophylaxis | cost savingsx 6 |
This year, new measures related to overweight and obesity are presented in the NHDR. In this section, measures for counseling obese adults about overweight and exercise are presented. In Chapter 4, Priority Populations, a measure for counseling children about overweight is presented in the section on children.
Over 32% of adults age 20 and older in the United States are obese,xi,19 putting them at increased risk for many chronic, deadly conditions such as hypertension, cancer, diabetes, and coronary heart disease.20 Reducing obesity is a major objective in preventing heart disease and stroke.21 Although physician guidelines recommend that health care providers screen all adult patients for obesity,22 obesity remains underdiagnosed among U.S. adults.23 The health care system has a central role to play in helping people become aware of the risks of obesity when they are overweight and suggesting strategies for reducing these risks.
x Unlike other interventions which often involve greater costs for health benefits, this intervention actually results in net cost savings to society.
xi Obesity is defined as having a body mass index (BMI) of 30 or higher. It is noteworthy that BMI incorporates both a person's weight and height in determining if he or she is overweight or obese.
Figure 2.8. Obese adults (body mass index of 30 or higher) age 20 and over who were told by a doctor or health professional that they were overweight by race/ethnicity, income, and education, 1999-2002

Source: National Health and Nutrition Examination Survey, 1999-2002
Reference population: Civilian noninstitutionalized population age 20 and over.
Note: Whites and Blacks are non-Hispanic populations. Education groups are for adults age 25 and over only. Rates other than the total are age adjusted to the 2000 standard population.
Exercise counseling within the clinical setting is an important component of effective weight loss interventions.22 Regular exercise aids in weight loss and blood pressure control efforts, reducing the risk of heart disease, stroke, diabetes, and other diseases.
Figure 2.9. Obese adults (body mass index of 30 or higher) who were given advice about exercise by race, ethnicity, income, and education, 2002 and 2003
Key: AI/AN=American Indian or Alaska Native.
Source: Medical Expenditure Panel Survey, 2002 and 2003.
Reference population: Civilian noninstitutionalized population age 18 and over.
Each year, multivariate analyses are conducted in support of the NHDR to identify the independent effects of race, ethnicity, and socioeconomic status on quality of health care. Past reports have listed some of these findings. This year, the NHDR presents the results of a multivariate model for one measure: obese adults who were given advice about exercise. Adjusted odds ratios are shown to quantify the relative magnitude of disparities after controlling for a number of confounding factors.
Figure 2.10. Obese adults (body mass index of 30 or higher) who were given advice about exercise: Adjusted odds ratios, 2002 and 2003

Source: Medical Expenditure Panel Survey, 2002 and 2003.
Reference population: Obese civilian noninstitutionalized population ages 18-64.
Note: Adjusted odds ratios are calculated from logistic regression models controlling for race, ethnicity, income, education, insurance, age, gender, and residence location. White, non-Hispanic White, high income, some college, and private insurance are reference groups with odds ratio=1; odds ratios <1 indicate that group is less likely to receive service than reference group. For example, compared with obese adults with private insurance, the chances that obese adults with no insurance were given advice about exercise is 0.63 after controlling for other factors. Another way to state this is that obese adults with no insurance are 37% less likely than obese adults with private insurance to receive advice about exercise.
Recommended hospital care for heart failure includes evaluation of the left ventricular ejection fraction and receipt of an ACE inhibitor for the left ventricular systolic dysfunction.
Figure 2.11. Recommended hospital care received by Medicare patients with heart failure, by race/ethnicity, 2002-2004

Key: AI/AN=American Indian or Alaska Native.
Source: Medicare Quality Improvement Organization program, 2002-2004.
Denominator: Medicare beneficiaries hospitalized for heart failure, all ages.
Note: Whites, Blacks, AI/ANs, and Asians are non-Hispanic groups. Composite incorporates the following measures: (1) receipt of evaluation of left ventricular ejection fraction, and (2) receipt of ACE inhibitor for left ventricular systolic dysfunction. Composite is calculated by averaging the percentage of the population that received each of the two incorporated components of care. For further details on composite measures, see Chapter 1, Introduction and Methods.
| Type of statistic | Number |
|---|---|
| Number of AIDS deaths (2004) | 15,79824 |
| Number of persons in the U.S. living with HIV (2003 est.) | 1,039,000-1,185,00025 |
| Number of persons living in the U.S. with AIDS (2004) | 415,19324 |
| New cases of HIV annually (2003 est.) approximately | 40,00025 |
| New AIDS cases (2004 est.) | 42,51424 |
| Federal spending on HIV/AIDS care (fiscal year 2004) | $11.6 billion26 |
Management of chronic HIV disease includes outpatient and inpatient services. Because national data on HIV care are not routinely collected, HIV measures tracked in NHDR come from the HIV Research Network, which consists of 18 medical practices across the United States that treat large numbers of HIV patients. Although program data are collected from all Ryan White CARE Act grantees,27 the aggregate nature of the data make it difficult to assess the quality of care provided by Ryan White CARE Act providers. Without adequate treatment, as HIV disease progresses, CD4 cell counts fall and patients become increasingly susceptible to opportunistic infections. When CD4 cell counts fall below 200, medicine to prevent development of Pneumocystis pneumonia (PCP) is routinely recommended; when CD4 cell counts fall below 50, medicine to prevent development of disseminated Mycobacterium avium complex (MAC) infection is routinely recommended.28
Figure 2.12. HIV patients with CD4 cell count <200 who received PCP prophylaxis in the past year, by race/ethnicity, 2003

Source: HIV Research Network, 2003.
Reference population: HIV patients age 18 and older receiving care from HIV Research Network providers.
Note: Whites and Blacks are non-Hispanic populations.
Figure 2.13. HIV patients with CD4 cell count <50 who received MAC prophylaxis in the past year, by race/ethnicity, 2003

Source: HIV Research Network, 2003.
Reference population: HIV patients age 18 and older receiving care from HIV Research Network providers.
Note: Whites and Blacks are non-Hispanic populations.
Currently, existing comprehensive data on HIV infection rates across the Nation are lacking; however, early and appropriate treatment of HIV disease can delay progression to AIDS. Improved management of chronic HIV disease has likely contributed to declines in new AIDS cases. For example, as the use of highly active antiretroviral therapy (HAART) to treat HIV infection became widespread in the mid-1990s, rates of new AIDS cases declined.29,30
Figure 2.14. New AIDS cases per 100,000 population age 13 and over, by race/ethnicity, 1998-2004

Key: API=Asian or Pacific Islander; AI/AN=American Indian or Alaska Native.
Source: HIV/AIDS Reporting System, 1998-2004.
Reference population: U.S. population age 13 years and over.
Note: The source categorizes race/ethnicity as a single item. White=non-Hispanic White; Black=non-Hispanic Black.
| Type of statistic | Number |
|---|---|
| Cause of death rank - suicide (2003) | 11th4 |
| Alcohol-related motor vehicle deaths (2004) | 16,69431 |
| Students grades 9-12 who have seriously considered suicide (2005) | 16.9%32 |
| People 12 or older with alcohol and/or illicit drug dependence or abuse (2004) | 22,506,00033 |
| People 18 or older with diagnosable mental disorder (2004) | 21,417,00033 |
| Adults with co-occurring diagnosable mental disorder and substance dependence or abuse (2004) | 4,600,00033 |
| Youth ages 12-17 with a major depressive episode during the past year | 2,225,000 (9.0 %)34 |
| Adults 18 and older with a major depressive episode during the past year | 17,100,000 (8.0%)35 |
| Lifetime prevalence of major depressive disorder | 9.5%36 |
| Lifetime prevalence of dysthymic disorder | 6.1%36 |
| People with any mental disorder in past year, U.S. (2001-2003) | 28.1%37 |
| People with anxiety disorders, U.S. (2001-2003) | 18.7%37 |
| People with mood disorders, U.S. (2001-2003) | 9.7%37 |
| People with impulse-control disorders, U.S. (2001-2003) | 10.4%37 |
| People with substance abuse disorders, U.S. (2001-2003) | 7.2%37 |
| Direct medical expenditures for substance abuse and mental disorders (2001 est.) | $104 billion38 |
| Cost effectiveness of problem drinking screening and brief counseling | $14,000-$35,000/QALY6 |
In a cross-national survey among adults in 14 countries conducted from 2001-2003, the United States had the highest rate with any mental disorders including substance abuse.xii, 39 The proportion of those with any mental disorders was 26%. The 12-month prevalence of anxiety disorders in the United States is 18%; mood disorders, 10%; impulse-control disorder, 7%; and any substance disorder is 4%.Mental health and substance abuse treatment quality improvement programs have been shown to improve outcomes and reduce costs.37
Suicide is often the result of untreated depression, and may be prevented when its warning signs are detected and treated. However, cultural, religious, or social stigma in certain population groups prevents the acknowledgment of the condition and hinders seeking care for depression, suicidal ideation, and related conditions.40, 41, 42 As a result, suicides are often underreported. Suicide rates should be used cautiously as a measure of differences in access to quality care among population groups, especially among racial and ethnic groups.43, 44
xii Readers should note that, to some extent, this finding may be attributable to different rates of screening and diagnosis for different countries.
Treatment for depression is an effective way to reduce the chances of future major depressive episodes. However, cost of care, societal stigma, and fragmented organization of services represent significant barriers to treatment for depression.45
Figure 2.15. Adults with a major depressive episode in the past year who received treatment for depression in the past year, 2004

Source: Substance Abuse and Mental Health Services Administration, National Survey on Drug Use and Health, 2004.
Reference population: U.S. population age 18 and older who had a major depressive episode in the past year.
Note: Major depressive episode is defined as a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of the symptoms for depression as described in the 4th edition of the Diagnostic and Statistical Manual of Mental Health Disorders (DSM-IV).
Illicit drugxiii use is a medical problem that can have a direct toxic effect on a number of body organs as well as exacerbate numerous health and mental health conditions. Treatment for illicit drug use at a specialty facility is an effective way to reduce the chances of future illicit drug use.
Figure 2.16. Persons age 12 and over who needed treatment for illicit drug use and received it at a specialty facility in the past year, 2002-2004

Source: Substance Abuse and Mental Health Services Administration, National Survey on Drug Use and Health, 2004.
Reference population: U.S. population age 12 and over who needed treatment for illicit drug use in the past year.
Note: Estimates by education were only available for persons age 18 and over. Received illicit drug treatment at a specialty facility refers to treatment received at a hospital (inpatient), a rehabilitation facility (inpatient or outpatient), or mental health center in order to reduce or stop drug use, or for medical problems associated with drug use. Respondents were classified as needing treatment for an illicit drug problem if they met at least one of the three criteria during the past year: (1) dependent on any illicit drug; (2) abuse of any illicit drug; or (3) received treatment for an illicit drug problem at a specialty facility (i.e., drug and alcohol rehabilitation facilities [inpatient or outpatient], hospitals [inpatient only], and mental health centers).
xiii Illicit drugs included in this measure are marijuana/hashish, cocaine (including crack), inhalants, hallucinogens, heroin, or prescription-type psychotherapeutic (non-medical use) drugs.
| Type of statistic | Number |
|---|---|
| Number of deaths due to lung diseases (2001) | 231,54546 |
| Number of deaths, influenza and pneumonia combined (2003) | 64,8474 |
| Cause of death rank, influenza and pneumonia combined (2003) | 7th4 |
| People 18 or over with an asthma attack in past 12 months, U.S. (2003) | 13,623,00047 |
| People under 18 with an asthma attack in past 12 months, U.S. (2003) | 3,975,00048 |
| Annual number of cases of the common cold in the U.S. (est) | > 1 billion49 |
| Annual number of pneumonia cases due to Streptococcus pneumoniae | 4,800,00050 |
| Total cost of lung diseases (2006 est.) | $144.2 billion5 |
| Direct medical costs of lung diseases (2006 est.) | $87.0 billion5 |
| Total approximate cost of upper respiratory infections (annual) | $40 billion51 |
| Total cost of asthma (2004) | $27.6 billion46 |
| Direct medical costs of asthma (2004) | $11.5 billion46 |
| Cost effectiveness of tobacco use screening and brief intervention | cost savings6 |
| Cost effectiveness of influenza immunization | $0-$14,000/QALY6 |
| Cost effectiveness of pneumococcal immunization | cost savings6 |
Vaccination is an effective strategy for reducing illness, death, and disparities associated with pneumococcal disease and influenza.52, 53
Figure 2.17. Adults age 65 and over who ever had pneumococcal vaccination, by race, ethnicity, income, and education, 1999-2004
Source: National Health Interview Survey, 1999-2003.
Reference population: Civilian noninstitutionalized population age 65 and over.
Note: Age adjusted to the 2000 standard population.
Racial and ethnic minorities are disproportionately of lower socioeconomic status. To distinguish the effects of race, ethnicity, income, and education on pneumococcal vaccination, this measure is stratified by income and education level.
Figure 2.18. Adults age 65 and over who ever had pneumococcal vaccination, by race and ethnicity, stratified by income, 2004
Source: National Health Interview Survey, 2004.
Reference population: Civilian noninstitutionalized population age 65 and older.
Note: Age adjusted to the 2000 standard population. Estimates are not available for high income Hispanics.
Figure 2.19. Adults age 65 and over who ever had pneumococcal vaccination, by race and ethnicity, stratified by education, 2004
Source: National Health Interview Survey, 2004.
Reference population: Civilian noninstitutionalized population age 65 and older.
Note: Age adjusted to the 2000 standard population.
Improving quality of care for people with asthma can reduce the occurrence of asthma attacks and avoidable hospitalizations. The National Asthma Education and Prevention Program (NAEPP), coordinated by the National Heart, Lung and Blood Institute, develops and disseminates science-based guidelines for the diagnosis and management of asthma.54 These recommendations are built around four essential components of asthma management critical for effective long-term control of asthma: assessment and monitoring, controlling factors contributing to symptom exacerbation, pharmacotherapy, and education for partnership in care.55
The National Asthma Survey in 2003, sponsored by the CDC National Center for Environmental Health and conducted by the National Center for Health Statistics, is the most comprehensive national data set on asthma prevalence and asthma care. It examines the health, socioeconomic, behavioral, and environmental predictors that relate to better control of asthma.
Counseling persons with asthma about recognizing an attack. Patient self-assessment is one of the primary methods for monitoring asthma. Patients should be trained to recognize symptom patterns indicating inadequate asthma control and the need for additional therapy.
Figure 2.20. Persons with current asthma who reported they were taught to recognize early signs of an attack, by race, ethnicity, income, and education, 2003

Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Asthma Survey, 2003.
Reference population: Civilian noninstitutionalized population with asthma, all ages. Education groups are for adults age 25 and over only.
Note: Numerical income categories are used in place of the NHDR's usual descriptive categories because that is how data are collected for this measure.
Counseling persons with asthma about changing their environment. Environmental tobacco smoke, dust mites, cockroaches, and animal allergens can trigger asthma exacerbations in sensitized persons. Ways of controlling environmental triggers and reducing exposure to environmental allergens and irritants should be discussed with asthma patients.
Figure 2.21. Persons with current asthma who reported they were told how to change their environment to help control their asthma, by race, ethnicity, income, and education, 2003

Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Asthma Survey, 2003.
Reference population: Civilian noninstitutionalized population with asthma, all ages. Education groups are for adults age 25 and over only.
Note: Numerical income categories are used in place of the NHDR's usual descriptive categories because that is how data are collected for this measure.
Use of a controller medication. Daily long-term control medication is necessary to prevent exacerbations and chronic symptoms for all patients with persistent asthma. Appropriate controller medications for people with mild persistent asthmaxiv,55,56 include inhaled corticosteroids, cromolyn, nedocromil, theophylline, or leukotriene modifiers.57
Figure 2.22. Persons with current asthma who reported using a controller medication in the past 3 months, by race, ethnicity, income, and education, 2003

Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Asthma Survey, 2003.
Reference population: Civilian noninstitutionalized population with asthma, all ages. Education groups are for adults age 25 and over only.
Note: Numerical income categories are used instead of the NHDR's usual descriptive categories because that is how data are collected for this measure.
xiv "Mild persistent asthma" refers to people who experience asthma symptoms more than 2 days per week, more than 2 nights per month, and other clinical indicators.
Receipt of an asthma management plan. Providers should develop a written plan as part of educating patients regarding self management, especially for patients with moderate or severe persistent asthma and those with a history of severe exacerbation.
Figure 2.23. Persons with current asthma who reported they received an asthma management plan, by race, ethnicity, income, and education, 2003

Source: Centers for Disease Control and Prevention, National Center for Health Statistics, National Asthma Survey, 2003.
Reference population: Civilian noninstitutionalized population with asthma, all ages. Education groups are for adults age 25 and over only.
Note: Numerical income categories are used instead of the NHDR's usual descriptive categories because that is how data are collected for this measure.
Approximately 5 million cases of pneumonia occur annually and result in nearly 55 million days of restricted activity, 31.5 million bed days, and 1.3 million hospitalizations each year.58 The Centers for Medicare & Medicaid Services tracks a set of measures for quality of pneumonia care for hospitalized patients from the CMS Quality Improvement Organization (QIO) program which has been adopted by the Hospital Quality Alliance (HQA).
Figure 2.24. Recommended hospital care received by Medicare patients with pneumonia, by race/ethnicity, 2002-2004

Key: AI/AN=American Indian or Alaska Native.
Source: Quality Improvement Organization program, 2002-2004.
Denominator: Medicare beneficiaries with pneumonia who are hospitalized, all ages.
Note: Whites, Blacks, Asians, and AI/ANs are non-Hispanic groups. Composite includes the following five measures: (1) receipt of antibiotics within 4 hours, (2) receipt of appropriate antibiotics, (3) receipt of blood culture before antibiotics, (4) receipt of influenza screening (i.e., person is assessed as to whether he or she would be a good candidate for vaccination) or vaccination, and (5) receipt of pneumococcal screening or vaccination. Composite is calculated by averaging the percentage of opportunities for care in which the patient received all five incorporated components of care. For further details on composite measures, see Chapter 1, Introduction and Methods.
xv "Recommended hospital care" is a composite of five separate measures (see Note to Figure 2.24 above for a list of these measures). For further details on composite measures, see Chapter 1, Introduction and Methods.
| Type of statistic | Number |
|---|---|
| Number of nursing home residents (1999) | 1,600,00059 |
| Number of home health patients (2000) | 1,460,80060 |
| Number of current hospice care patients (2000) | 105,50061 |
| Discharges from nursing homes (1998-1999) | 2,500,00059 |
| Discharges from home health agencies (2000) | 7,800,10060 |
| Discharges from hospice care (2000) | 621,00061 |
| Total cost of nursing home services (2003) | >$110.8 billion62 |
| Total cost of home health services (2003) | $40 billion62 |
| Annual national expenditures for hospice care for decedents (1992-1996) | $1.232 billion63 |
| Percent of health care expenditures for hospice care in last 6 months of life | 74%63 |
This section highlights two core measures of nursing home quality of care—use of physical restraints and presence of pressure sores—and two measures of home health care quality—improvement in walking or moving around and episodes with acute care hospitalization.
While restraining nursing home residents is sometimes a component of keeping residents safe and well cared for, residents who are restrained daily can become weak, lose their ability to go to the bathroom by themselves, and develop pressure sores or other medical complications. Restraints should be used only when they are necessary as part of the medical treatment.
Figure 2.25. Long-stay nursing home residents who were physically restrained by race/ethnicity, 1999-2004

Key: API=Asian or Pacific Islander; AI/AN=American Indian or Alaska Native.
Source: CMS Minimum Data Set, 1999-2004. Data are from the third quarter of each calendar year.
Denominator: Long-stay nursing home residents, all ages.
Note: White, Black, API, and AI/AN are non-Hispanic groups. Long-stay residents are persons in an extended/permanent nursing home stay.
A pressure ulcer, or pressure sore, is an area of broken-down skin caused by sitting or lying in one position for an extended period of time. Residents should be assessed by nursing home staff for presence or risk of developing pressure sores. Nursing homes can help to prevent or heal pressure sores by keeping residents clean and dry and by changing their position frequently or helping them move around, making sure residents get proper nutrition, and using soft padding to reduce pressure on the skin. However, some residents may get pressure sores even when a nursing home provides good preventive care.
Figure 2.26. Long-stay high-risk nursing home residents and short-stay residents who developed pressure sores, by race/ethnicity, 1999-2004
Key: API=Asian or Pacific Islander; AI/AN=American Indian or Alaska Native.
Source: CMS Minimum Data Set, 1999-2004. Data for long-stay residents are from the third quarter of each calendar year. Data for short-stay residents are full calendar year estimates.
Denominator: Long-stay nursing home residents (left), and short-stay nursing home residents (right).
Note: White, Black, API, and AI/AN are non-Hispanic groups. Long-stay residents are persons in an extended/permanent nursing home stay. Short-stay residents are persons needing skilled nursing care or rehabilitation services following a hospital stay but who are expected to return home.
xvi High-risk residents are those who are in a coma, who do not get or absorb the nutrients they need, or who cannot move or change position on their own. Conversely, low-risk residents can be active, can change positions, and are getting and absorbing the nutrients they need.
How well a patient improves in ability level while getting home health care is a reflection of the provider's quality of service, the patient's level of cooperation, and the patient's available support system. Improved ambulation, i.e., getting better at walking or using a wheel chair, is a measure of improved outcomes.xvii
Figure 2.27. Home health care episodes with patients who get better at walking or moving around, by race and ethnicity, 2002-2004
Key: NHOPI=Native Hawaiian or Other Pacific Islander; AI/AN=American Indian or Alaska Native.
Source: CMS Outcome and Assessment Information Set, 2002-2004.
Denominator: Patients with home health care episodes.
Note: An episode is the time during which a patient is under the direct care of a home health agency. It starts with the beginning/resumption of care and finishes when the patient is discharged from home health care or transferred to an inpatient facility. Some patients have multiple episodes in a year.
xvii In cases of patients with some neurological conditions, such as progressive multiple sclerosis or Parkinson's disease, ambulation may not improve even when the nursing home or home health service provides good care.
Improvement in the acute care hospitalization outcome is demonstrated by a decrease in the percentage of patients who had to be admitted to the hospital; lower percentages are the desirable outcome. However, patients may need to go into the hospital while they are getting care; and, in some instances, this may not be avoidable even with good home health care. Acute care hospitalization may be avoided if the home health staff adequately checks the patient's health condition at each visit to detect problems early.
Figure 2.28. Home health care episodes with patients who were admitted to the hospital, by race and ethnicity, 2002-2004
Key: NHOPI=Native Hawaiian or Other Pacific Islander; AI/AN=American Indian or Alaska Native.
Source: CMS Outcome and Assessment Information Set, 2002-2004.
Denominator: Patients with home health care episodes.
Note: An episode is the time during which a patient is under the direct care of a home health agency. It starts with the beginning/resumption of care and finishes when the patient is discharged from home health care or transferred to an inpatient facility. Some patients have multiple episodes in a year.
Hospice care is generally delivered at the end of life to patients with a terminal illness or condition requiring comprehensive medical care; it also includes psychosocial and spiritual support for the patient and family. The goal of end-of-life care is to achieve a "good death" defined by the IOM as one that is "free from avoidable distress and suffering for patients, families, and caregivers; in general accord with the patient's and families' wishes; and reasonably consistent with clinical, cultural, and ethical standards."64 The National Hospice and Palliative Care Organization's Family Evaluation of Hospice Care survey examines the quality of hospice care for patients and their family members. Family respondents report how well hospices respect patient wishes, communicate about illness, control symptoms, support dying on one's own terms, and provide family emotional support.xviii, 65
Pain management. Addressing the comfort aspects of care, such as relief from pain, fatigue, and nausea, is an important component of hospice care.xix
Figure 2.29. Hospice patients who did not receive the right amount of medicine for pain, by race, ethnicity, and education, 2005

Key: AI/AN=American Indian or Alaska Native; API=Asian or Pacific Islander.
Source: National Hospice and Palliative Care Organization Family Evaluation of Hospice Care, 2005.
Denominator: Adult hospice patients.
xviii This survey provides unique insight into end-of-life care and captures information about a large proportion of hospice patients but is limited by non-random data collection and a response rate of about 40%. In addition, race and ethnicity were not reported by large numbers of respondents. These limitations should be considered when interpreting these findings.
xix This measure is based on responses from a family member of the deceased. In interpreting it, it should be noted that family members may or may not be able to determine whether the right amount of medicine for pain was administered.
End-of-life care. End-of-life care should respect a patient's stated end-of-life wishes. This includes shared communication and decision-making between providers, patients, and family members and respect of cultural beliefs.
Figure 2.30. Hospice patients who received care inconsistent with their stated end-of-life wishes, by race, ethnicity, and education, 2005

Key: AI/AN=American Indian or Alaska Native; API=Asian or Pacific Islander.
Source: National Hospice and Palliative Care Organization Family Evaluation of Hospice Care, 2005.
Denominator: Adult hospice patients.
| Type of statistic | Number |
|---|---|
| Number of Americans that die each year from medical errors (1999 est) | 44,000-98,00066 |
| Number of Americans that die in the hospital each year due to 18 types of medical injuries (2000 est) | at least 32,00067 |
| Rate of adverse drug reactions in hospital admissions | 2.0%-6.7%68, 69, 70, 71 |
| Rate of adverse drug events among Medicare beneficiaries in ambulatory settings | 50 per 1,000 person-years |
| Percentage of serious, life-threatening, or fatal events deemed preventable | 40% |
| Cost (in lost income, disability, and health care costs) attributable to medical errors (1999 est) | $29 billion66 |
| Groups with higher rates of some safety events | racial minorities72, 73 |
This section highlights six measures of patient safety in three areas: postoperative complications, other complications of hospital care, and complications of medications. (For findings related to all core measures of patient safety, go to Table 2.2a.)
Adverse health events can occur during episodes of care, especially during and right after surgery. Although some of the events may be related to a patient's underlying condition, many of them can be avoided if adequate care is provided.
Postoperative care composite. Patients are vulnerable to experiencing a variety of complications soon after they undergo surgery. Complications may include, but are not limited to, pneumonia, bladder infection, and blood clots in the legs.
Figure 2.31. Surgical patients with postoperative care complications, by race, 2003 and 2004

Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System, 2003-2004.
Denominator: Hospitalized Medicare patients having surgery, all ages.
Note: Postoperative care complications included in this composite are postoperative pneumonia, urinary tract infection, and venous thromboembolic event (blood clot in the leg).
Postoperative wound infections. Infections acquired during hospital care (nosocomial infections) are among the most serious safety concerns. A common hospital-acquired infection is a wound infection following surgery. Hospitals can reduce the risk of wound infection after surgery by making sure patients get the right antibiotics at the right time on the day of their surgery. Research shows that surgery patients who get antibiotics within the hour before their operation are less likely to get wound infections; getting an antibiotic earlier, or after surgery begins, is not as effective. However, taking these antibiotics for more than 24 hours after routine surgery is usually not necessary and can increase the risk of side effects such as stomach aches, serious types of diarrhea, and antibiotic resistance. Among adult Medicare patients having surgery, the NHDR tracks a composite of two measures: receipt of antibiotics within 1 hour prior to surgical incision and discontinuation of antibiotics within 24 hours after end of surgery.
Figure 2.32. Appropriate timing of antibiotics received among adult surgical Medicare patients, by race/ethnicity, 2004

Key: AI/AN=American Indian or Alaska Native.
Source: Medicare Quality Improvement Organization Program, 2004.
Denominator: Medicare patients age 18 and over having surgery.
Note: Whites, Blacks, Asians, and AI/ANs are non-Hispanic groups.
Types of care delivered in hospitals, in addition to surgery, can place patients at risk for injury or death.
Adverse events associated with central venous catheters. Patients who require a central venous catheter to be inserted into the great vessels of their heart tend to be severely ill. However, the procedure itself can result in a number of infectious and non-infectious complications.
Figure 2.33. Central venous catheter complications, by race, 2003 and 2004

Source: Medicare Patient Safety Monitoring System, 2003 and 2004.
Denominator: Hospitalized Medicare patients with central venous catheter placement, all ages.
Note: Central venous catheter complications included in this composite are bloodstream infection and mechanical adverse events.
Deaths following complications of care. Many complications that arise during hospital stays cannot be prevented. However, rapid identification and aggressive treatment of complications may prevent these complications from leading to death. This indicator, also called "failure to rescue," tracks deaths among patients whose hospitalizations are complicated by pneumonia, thromboembolic event, sepsis, acute renal failure, shock, cardiac arrest, and gastrointestinal bleeding or acute ulcer.
Figure 2.34. Deaths per 1,000 patients following complications of care by race/ethnicity, 2001-2003

Key: API=Asian or Pacific Islander.
Source: HUCP State Inpatient Databases disparities analysis file, 2001-2003.
Denominator: Patients less than 75 years old from U.S. community hospitals whose hospitalization is complicated by pneumonia, thromboembolic event, sepsis, acute renal failure, shock, cardiac arrest, and gastrointestinal bleeding or acute ulcer.
Complications of medication are common safety problems. Some adverse drug events may be related to misuse of medication but others are not. However, prescribing medications that are inappropriate for a specific population may increase the risk of adverse drug events.
Adverse drug events in the hospital. Some medications used in hospitals can cause serious complications. The Medicare Patient Safety Monitoring System tracks a number of adverse drug events including serious bleeding associated with intravenous heparin, low molecular weight heparin, or warfarin and hypoglycemia associated with insulin or oral hypoglycemics.
Figure 2.35. Medication-related adverse drug events among Medicare inpatients, by race, 2004

Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System, 2004.
Denominator: Random sample of Medicare medical records, all ages.
Inappropriate medication use among the elderly. Some drugs that are appropriate for some patients are considered potentially harmful for elderly patients but nevertheless are prescribed to them.xx, 74
Figure 2.36. Inappropriate medication use by the elderly, 2000-2003

Source: Agency for Healthcare Research and Quality, Medical Expenditure Panel Survey, 2000-2003.
Reference population: Civilian noninstitutionalized population age 65 and over.
xx Drugs that should always be avoided for elderly patients include barbiturates, flurazepam, meprobamate, chlorpropamide, meperidine, pentazocine, trimethobenzamide, belladonna alkaloids, dicyclomine, hyoscyamine, and propantheline. Drugs that should often be avoided for elderly patients include carisoprodol, chlorzoxazone, cyclobenzaprine, metaxalone, methocarbamol, amitriptyline, chlordiazepoxide, diazepam, doxepin, indomethacin, dipyridamole, ticlopidine, methyldopa, reserpine, disopyramide, oxybutynin, chlorpheniramine, cyproheptadine, diphenhydramine, hydroxyzine, promethazine, and propoxyphene.
Timeliness is the health care system's capacity to provide care quickly after a need is recognized. For patients, lack of timeliness can result in emotional distress, physical harm, and financial consequences.75, 76 For example, stroke patients' mortality and long-term disability are largely influenced by the timeliness of therapy.77, 78 Timely delivery of appropriate care can also help reduce mortality and morbidity for chronic conditions such as chronic kidney disease,79 and timely antibiotic treatments are associated with improved clinical outcomes.80 Timely delivery of childhood immunizations helps maximize protection from vaccine-preventable diseases while minimizing risks to the child and reducing the chance of disease outbreaks.81
Early care for comorbid conditions has been shown to reduce hospitalization rates and costs for Medicare beneficiaries.82 Some research suggests that, over the course of 30 years, the costs of treating diabetic complications can approach $50,000 per patient.83 Early care for complications in patients with diabetes can reduce overall costs of the disease.84 Timely outpatient care can reduce admissions for pediatric asthma, which account for $1,257 million in total hospitalization charges annually.85 Measures of timeliness highlighted in this section include getting care for illness or injury as soon as wanted and emergency department visits where the patient left without being seen. (For findings related to all core measures of timeliness, go to Tables 2.3a and 2.3b.)
The ability of patients to receive illness and injury care in a timely fashion is a key element in a patient-focused health care system.
Figure 2.37. Adults age 18 and over who reported sometimes or never getting care for illness or injury as soon as wanted in the past year, by race, ethnicity, income, and education, 2002-2003

Source: Medical Expenditure Panel Survey, 2002 and 2003.
Reference population: Civilian noninstitutionalized population age 18 and older.
Racial and ethnic minorities are disproportionately of lower socioeconomic status. To distinguish the effects of race, ethnicity, income, and education on timeliness of primary care, this measure is stratified by income and education level.
Figure 2.38. Adults who reported sometimes or never getting care for illness or injury as soon as wanted in the past year, by race and ethnicity, stratified by income, 2003
Source: Medical Expenditure Panel Survey, 2003.
Reference population: Civilian noninstitutionalized population age 18 and older.
Figure 2.39. Adults who reported sometimes or never getting care for illness or injury as soon as wanted in the past year, by race and ethnicity, stratified by education, 2003
Source: Medical Expenditure Panel Survey, 2003.
Reference population: Civilian noninstitutionalized population age 18 and older.
In 2001, patients who had an emergency department (ED) visit in the United States spent an average of 3.2 hours waiting to be seen.86 This may reflect the 20% increase in ED visit volumes over the past 10 years, as the number of ED facilities has decreased by 15%.86 There are many reasons that a patient seeking care in an emergency department may leave without being seen, but long waits tend to exacerbate this problem.
Figure 2.40. Emergency department visits in which patient left without being seen, by race, 1997-2004

Source: National Hospital Ambulatory Medical Care Survey, 1997-2004.
Denominator: Visits by patients (of all ages) to the EDs of non-Federal, short-stay, and general hospitals, exclusive of military, and Department of Veterans Affairs hospitals.
The Institute of Medicine identifies patient centeredness as a core component of quality health care.2 Patient centeredness is defined as: "[H]ealth care that establishes a partnership among practitioners, patients, and their families (when appropriate) to ensure that decisions respect patients' wants, needs, and preferences and that patients have the education and support they need to make decisions and participate in their own care."87 Patient centeredness "encompasses qualities of compassion, empathy, and responsiveness to the need, values, and expressed preferences of the individual patient."88
Patient centered care is supported by good patient-provider communication so that patients' needs and wants are understood and addressed and patients understand and participate in their own care.87, 89, 90, 91 This style of care has been shown to improve patients' health and health care. 89, 90, 92, 93, 94 Unfortunately, there are barriers to good communication: about a third of Americans are suboptimally "health literate,"95, 96 which means they lack the "capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions."97 They receive less preventive care,98 and have poorer understanding of their conditions and care,95, 99, 100 higher use of emergency and inpatient services, higher rates of rehospitalization,101, 102 lower adherence to medications,101 and lower participation in medical decisionmaking.103 Low health literacy costs an estimated $29 billion to $69 billion per year.104 Providers also differ in communication proficiency, including varied listening skills and views of symptoms and treatment effectiveness, compared with their patients' views.105
Patient centeredness has been shown to reduce both underuse and overuse of medical services106 and can reduce strains on system resources or save money by reducing the number of diagnostic tests and referrals.92 Additional factors influencing patient centeredness and patient-provider communication include language barriers, racial/ethnic concordance between the patient and provider, effects of disabilities on patients' health care experiences, and providers' cultural competency. Efforts to improve these possible impediments to patient centeredness are underway. For example, the Office of Minority Health, part of the U.S. Department of Health and Human Services, has developed a set of Cultural Competency Curriculum Modules which aim to equip providers with cultural and linguistic competencies to help eliminate disparities.xxi, 107
The NHDR includes one core measure of patient centeredness—a composite measure on the patient experience of care. In addition, because having a diverse workforce of health care providers may be an important component of patient-centered health care for many patients, this year's report includes two new supplemental measures of workforce diversity—race/ethnicity of the Nation's physician workforce and race/ethnicity of the physicians who spent at least half of the work week in direct patient care—and one supplemental measure on patient-provider communication in the hospital.
xxi This online program (available at www.thinkculturalhealth.org) is accredited for 9 Continuing Medical Education credits for physicians and 10.8 and 0.9 Continuing Education Units for nurses and pharmacists, respectively.
Using methods developed for the CAHPS® (Consumer Assessment of Healthcare Providers and Systems108) survey, the NHDR uses a composite measure which combines four measures of the patient experience of care into a single core measure—providers who sometimes or never listen carefully, explain things clearly, respect what patients say, and spend enough time with patients. (For findings related to all core measures of patient centeredness, go to Tables 2.3a and 2.3b.)
Figure 2.41. Adults whose health providers sometimes or never listened carefully, explained things clearly, respected what they had to say, and spent enough time with them, by race, ethnicity, income, and education, 2002 and 2003

Key: AI/AN=American Indian or Alaska Native.
Source: Medical Expenditure Panel Survey, 2002 and 2003.
Denominator: Civilian noninstitutionalized population age 18 and older.
Racial and ethnic minorities are disproportionately of lower socioeconomic status. To distinguish the effects of race, ethnicity, income, and education on patient-provider communication, this measure is stratified by income and education level.
Figure 2.42. Adults whose health providers sometimes or never listened carefully, explained things clearly, respected what they had to say, and spent enough time with them by race and ethnicity, stratified by income, 2003
Source: Medical Expenditure Panel Survey, 2003.
Denominator: Civilian noninstitutionalized population age 18 and older.
Note: Sample sizes were too small to provide estimates for poor and near poor Asians.
Figure 2.43. Adults whose health providers sometimes or never listened carefully, explained things clearly, respected what they had to say, and spent enough time with them by race and ethnicity, stratified by education, 2003
Source: Medical Expenditure Panel Survey, 2003.
Denominator: Civilian noninstitutionalized population age 18 and older.
Note: Sample sizes were too small to provide estimates for Asians with less than a high school education and high school graduates. The seemingly large difference between middle income Asians and Whites is not statistically significant due to small sample sizes.
Health care workforce diversity